Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business9 December 2014Corporate and M&ADeal watchUS firms One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: Ropes hires Freshfields levfin co-head as top Kirkland litigator retiresThe ‘football managers’ of the legal world – why real estate PE partners are in high demandBeyond New York and London: the must-have locations for the global eliteSpread of transatlantic firms in the mix on Unilever’s $45bn food business sale‘The merger is working’ – HSF Kramer on its US corporate pushS&C, Kirkland, Skadden among Q1 M&A leaders as megadeals drive activity‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLegal 500 US: Latham tops the charts in new US rankingsDealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega deal